Our results indicate a strong association between low ZBTB38 expression in localised tumours with heightened levels of chromosomal instability as well as mutations of SPOP, which reinforce the association of ZBTB38 with aggressive prostate cancer. This evidence concerns the gene SPOP and prostate carcinoma.